La pneumopathie infiltrative diffuse au cours des connectivites : étude de 26 cas à l’hôpital Aristide Le Dantec de Dakar
Résumé
Texte intégral :
PDFRéférences
Duxbury B, Rochat T. Pneumopathies interstitielles liées aux connectivites. Rev Med Suisse. 2015; 11 : 2170-52. Just N. Pneumopathies interstitielles diffuses associées aux connectivites. Réalités Thérapeutiques en Dermato-Vénérologie. 2014 ; 229 : 15-223. Colby TV, Swensen SJ. Anatomic distribution and histopathologic patterns in diffuse lung disease: Correlation with hrct. J Thorac Imag. 1996; 11:1-264. Abehsera M, Valeyre D, Grenier P et al. Sarcoidosis with pulmonary fibrosis: Ct patterns and correlation with pulmonary function. AJR. 2000; 174:1751-17575. Assayag D, Elicker BM, Urbania TH et al. Rheumatoid arthritisassociated interstitial lung disease. Radiology 2014; 270: 583-86. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS executive committee, June 2001. Am J Respir Crit Care Med. 2002; 165: 277-3047. Solomon JJ, Olson AL, Fischer A et al. Scleroderma lung disease. Eur Respir Rev 2013; 22:6-198. Launay D, Remy-Jardin M, Michon-Pasturel U, et al. HRCT in fibrosing alveolitis associated with systemic sclerosis. J Rheumatol 2006; 33: 1789-8019. Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis, 2007; 66:940-944
Connors GR, Christopher-Stine L, Oddiset CV et al. Interstitial lung disease associated with the idiopathic inflammatory myopathies. Chest 2010; 138: 1464-7411. Marie I, Hachulla E, Cherin P et al. Interstitial lung disease in polymyositis and dermatomyositis. Arthritis and Rheumatism. 2002; 47: 614-62212. Shaw M, Collins BF, Ho LA et al. Rheumatoid arthritis-associated lung disease. Eur Respir Rev 2015; 24:1-1613. Turpin M. Approche thérapeutique des pneumopathies interstitielles diffuses liées aux connectivites. Revue des Maladies Respiratoires Actualités 2016 ; 8 : 142-14414. Gochuico BR, Avila NA, Chow CK, et al. Progressive preclinical interstitial lung disease in rheumatoid arthritis. Arch Intern Med 2008; 168:159-6615. Kim EJ, Collard HR, King TE. Rheumatoid arthritis associated interstitial lung disease. Chest 2009; 136: 1397-40516. Bongartz T, Nannini C, MedinaVelasquez YF, et al. Incidence and mortality of interstitital lung disease in rheumatoid arthritis. Arth Rheum 2010; 62: 1583-9117. Bouros D, Wells AU, Nicholson AG et al. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med, 2002; 165:1581-158618. Douglas WW, Tazelaar HD, Hartman TE et al. Polymyositisdermatomyositis-associated interstitial lung disease. Am J Respir CritCare Med 2001; 164: 1182-519. Cottin V, Thivolet-Béjui F, Reynaud-Gaubert M. et al. Interstitial lung disease in amyopathic dermatomyositis, dermato-myositis and polymyositis. Eur Respir J 2003; 22:245-5020. Raj R, Raparia K, Lynch DA, Brown KK. Surgical lungbiopsy for interstitial lung diseases. Chest 2017; 151:1131 4021. Vivero M, Padera RF. Histopathology of lung diseasein the connective tissue diseases. Rheum Dis Clin North Am 2015; 41:197-211 22. Fisher A, Brown KK, Du Bois RM, et al. Mycophenolate mofetil improves lung function in connective tissue disease-associated lung disease. J Rheumatol 2013; 40:5 23. Tashkin DP, Elashoff R, Clements PJ. Et al. Scleroderma Lung Study Research Group. Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. Am J Respir Crit Care Med 2007; 176:10
Renvois
- Il n'y a présentement aucun renvoi.